Authors: FRIEDMAN JH LANNON MC FACTOR S COMELLA C PARSA M PFEIFFER R RICHARDS I KURLAN R

Citation: Jh. Friedman et al., LOW-DOSE CLOZAPINE FOR THE TREATMENT OF DRUG-INDUCED PSYCHOSIS (DIP) IN IDIOPATHIC PARKINSONS-DISEASE (PD) - RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PSYCLOPS TRIAL, Neurology, 50(4), 1998, pp. 7002-7002

Authors: RICHARD IH KURLAN R TANNER C FACTOR S HUBBLE J SUCHOWERSKY O WATERS C GOETZ C JUNCOS JL STERN M HARRISON MB SETHI KD STANDAERT D TROSCH R REICH S KIEBURTZ K FEIGIN A MARSHALL FJ GAUTHIER S PANISSET M LEW ME FRIEDMAN JH PAULSON G RODNITZKY RL HAUSER R KURTH M HURTIG H THAL L ELMER LW PERLMUTTER JS GOLBE LI COMELLA C LANG A MARK MH SINGER C SHOULSON I WEINER WJ PFEIFFER R MAREK KL NUTT J WOOTEN GF JANKOVIC J LEWITT P HOEHN M BENNETT J PARSA M KOLLER W

Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077

Authors: KIEBURTZ K MCDERMOTT M SHOULSON I FAHN S BRIN M GOETZ C LANG A OLANOW CW LEWITT P MISTURA K WATERS C WELSH M RODNITZKY R DOBSON J ARGATOFF P TANNER C LEWIS P WATTS R BRYAN B COMELLA C JAGLIN JA SHULTS C FONTAINE D BRESSMAN SB MOSKOWITZ C HURTIG HI SHALLOW K HUBBLE J BARTER R BENNETT JP ROSTRUFFNER E PERLMUTTER JS MCGEEMINNICH L HAUSER R GAUGER L RAJPUT AH SUTTON A TRINIDAD K GARDINER IF SINGER C SHELDON C FINK JS TENNIS M BAKER D BOURGEOIS K CASACELI C CLAUDE K HICKEY G NOBEL R OAKES D ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH P SOTACK J WATTS A TARIOT PN GOLBE LI MILLER P HALL WJ HERNDON R DORFLINGER E MYL D MODI M OARSLEY L YOO K ELIAHOU E SHIMOUN G COLLETTA S SIEGEL J PEDDER S DUPUIS D

Citation: K. Kieburtz et al., EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE, Annals of neurology, 40(1), 1996, pp. 99-107

Authors: ANDERSON RL BLITZER A BRIN M CARRUTHERS A COMELLA C CONSKY E DUBINSKY R FAHN S FRUEH BR HALLETT M JANKOVIC J KOMAN A KRAFT SP LANG A LUDLOW C NAMEROW NS RHEW K SIMPSON LL TSUI J WATERS C WOODSON G

Citation: Rl. Anderson et al., TRAINING GUIDELINES FOR THE USE OF BOTULINUM TOXIN FOR THE TREATMENT OF NEUROLOGIC DISORDERS, Neurology, 44(12), 1994, pp. 2401-2403

Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L

Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347